{
    "applicationNumber": "BR 11 2023 005859-7",
    "filingDate": "29/09/2021",
    "grantDate": null,
    "title": "COMPOSTOS, COMPOSI\u00c7\u00c3O FARMAC\u00caUTICA E M\u00c9TODO PARA O TRATAMENTO DE C\u00c2NCER",
    "nationalPhaseDate": [
        "29/03/2023"
    ],
    "internationalApplication": {
        "pctNumber": "PCT CN2021/121562",
        "pctDate": "29/09/2021",
        "wipoNumber": null,
        "wipoDate": null
    },
    "priorityClaims": [
        {
            "countryCode": "CN",
            "priorityNumber": "PCT/CN2020/119171",
            "priorityDate": "30/09/2020"
        },
        {
            "countryCode": "CN",
            "priorityNumber": "PCT/CN2020/135968",
            "priorityDate": "11/12/2020"
        },
        {
            "countryCode": "CN",
            "priorityNumber": "PCT/CN2021/076993",
            "priorityDate": "20/02/2021"
        },
        {
            "countryCode": "CN",
            "priorityNumber": "PCT/CN2021/113967",
            "priorityDate": "23/08/2021"
        }
    ],
    "events": [
        {
            "code": "1.1",
            "description": "Publica\u00e7\u00e3o Internacional \u2013 PCT. Apresenta\u00e7\u00e3o de peti\u00e7\u00e3o de requerimento de entrada na fase nacional",
            "bulletinNumber ": "2727"
        },
        {
            "code": "1.3",
            "description": "Notifica\u00e7\u00e3o - Fase Nacional - PCT",
            "bulletinNumber ": "2739"
        }
    ],
    "inventors": [
        "SANJIA XU",
        "JING LI",
        "ZHIWEI WANG"
    ],
    "holders": [
        137118
    ],
    "ipcCodes": [
        "A61P 35/00",
        "A61K 31/4152",
        "C07D 403/14",
        "A61K 31/4965",
        "C07D 241/20",
        "C07D 231/20"
    ]
}